La búsqueda de China de conquistar el envejecimientonews2025-11-10T18:24:09+00:00November 10th, 2025|The New York Times|
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
Inside China’s Quest to Defy Aging with Longevity Labs and ‘Immortality Islands’news2025-11-08T10:55:21+00:00November 8th, 2025|The New York Times|
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrivenews2025-03-31T11:00:05+00:00March 31st, 2025|The New York Times|
How A.I. Is Revolutionizing Drug Developmentnews2024-06-17T09:03:08+00:00June 17th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
A Fraught New Frontier in Telehealth: Ketaminenews2023-02-20T08:00:06+00:00February 20th, 2023|The New York Times|
Start-Up Paradigm Raises $200 Million to Speed Up Drug Trialsnews2023-01-27T10:00:17+00:00January 27th, 2023|The New York Times|
Startups Prescribing A.D.H.D Drugs on TikTok Raise Diagnosis Concernsnews2022-05-13T21:12:48+00:00May 13th, 2022|The New York Times|
Elizabeth Holmes Trial: Closing Arguments Are Set to Beginnews2021-12-17T00:07:25+00:00December 17th, 2021|The New York Times|
